Vivus, Inc. recalls PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Camp…

Recall date

June 23, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0896-2023

FDA classification

Class III

Brand / firm

Vivus, Inc.

Sold / distributed

Nationwide within the United States

Why it was recalled

Failed Stability Specifications

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,